Nemerarsquos Next Generation Nasal Spray Advanciareg Is Now In Production With 45 Million Units39 Annual Capacitynemera Has Invested More Than 10 Million Euros In Rampd And Manufacturing To Launch The Only Userindependent Multidose Nasal Spray System On The Marketso Far The Drug Product Packaging For Advanciareg Is Approved In One European Countryadvanciareg Represents A Major Breakthrough In Nasal Drug Delivery By Providing Patients With A Userindependent System Ideal For Topical And Systemic Preserved Drugs In A Userfriendly Packagepatient Noncompliance With Therapy Could Result In Ineffective Treatment Orin The Case Of Potent Drugs Harmful Effects In Patientsthe New Userindependent Nasal Spray Packaging Advanciareg Guarantees A Consistent Dose And Spray Irrespective Of The Manner In Which The Patient Uses Itthis Userindependent Device Is Able To Deliver Excellent Dose Consistency Exceeding The Most Stringent Regulatory Requirements Moreover With Its Anticlogging Technology The System Ensures Spray Delivery Even With Formulations That Tend To Crystallize As A Result Patients Are Not Required To Cleanthe Actuator After Each Use The Extended Prime Retention Of Up To Several Months Offers A Unique Solution For Drugs For Which Treatment Needs Are Infrequent Hence The Patients Do Not Have To Reprime The Pump To Ensure Full Delivery Of The Dose After Several Weeks Of Nonuse This Also Limits Drug Waste No Spray Loss All These Features Improve Patient Complianceadvanciareg Offers Several Major Advantagesuserindependenceexcellent Dose Consistencylong Prime Retentionmechanical Closing Tip To Prevent Problems Due To Cloggingno Metal Part In Contact With The Formulationcompatible With Fea 20mm Crimpon Neck Finish Bottles Plastic Or Glassfind Nemera On The Web At Wwwnemeranetnemera Is One Of The World Leaders In The Design Development And Manufacturing Of Drug Delivery Solutions Its Expertise Covers All Five Modes Of Delivery Nasalbuccalauricular Spray Pumps Actuators Valves Etc Ophthalmic Preservativefree Multidose Eyedroppers Pulmonary Pmdi Mdirsquos Dpirsquos Dermal Transdermal Airless Amp Atmospheric Dispensers And Parenteral Autoinjectors Pens And Safety Devicesnemera Provides Solutions For The Pharmaceutical Industry Including Standardinnovative Products The Development Of Proprietary Devices And Contract Manufacturing The Advanciareg Innovative Project Is Cofinanced By The European Union Europe Is Committed In Normandy With The European Regional Development Fund Feder
